Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Aug;85(3):372–378. doi: 10.1054/bjoc.2001.1873

Population-based case–control study of soyfood intake and breast cancer risk in Shanghai

Q Dai 1,5, X-O Shu 1, F Jin 2, J D Potter 3, L H Kushi 4, J Teas 5, Y-T Gao 2, W Zheng 1
PMCID: PMC2364075  PMID: 11487268

Abstract

We evaluated the association of soyfood intake and breast cancer risk in a population-based case–control study among Chinese women in Shanghai. Included in the study were 1459 cases and 1556 age-matched controls, with respective response rates of 91.1% and 90.3%. Usual soyfood intake was assessed using a food frequency questionnaire (FFQ). Separate analyses were performed for all subjects and for the subset who reported no recent change in soyfood intake. The intake levels of soyfoods among women in Shanghai are high, with 96.6% women reporting soyfood consumption at least once a week. A statistically non-significant reduced risk (odds ratio (OR) = 0.78 95% CI = 0.52–1.16) of breast cancer was observed among those who reported eating soyfood at least once a week. Compared to those in the lowest decile intake group, women in the highest decile intake group had a 30% reduced risk of breast cancer (OR = 0.66, 95% CI = 0.46–0.95), but no monotonic dose–response relation was observed (P for trend, 0.28). Stratified analyses showed that the inverse association was restricted primarily among women who had a high body mass index (BMI), with an adjusted OR of 0.30 (95% CI = 0.10–0.94) observed for the highest intake group. The reduction in risk was stronger for breast cancer positive for both oestrogen receptor (ER) and progesterone receptor (PR) (OR = 0.44, 95% CI = 0.25–0.78) than those with other ER/PR status. More pronounced inverse associations were observed in analyses among those who reported no recent change in soyfood intake than those conducted in all subjects. A dose–response relation between soyfood intake and breast cancer risk was observed in this subset of women (P for trend, 0.02), with an OR of 0.46 (95%CI = 0.28–0.75) for those in the highest decile intake group. No clear monotonic dose–response relation was found between soyfood intake and breast cancer risk among regular soy eaters, but nevertheless the results suggest that regular soyfood consumption may reduce the risk of breast cancer, particularly for those positive for ER and PR; the effect may be modified by body mass index. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: breast cancer, body mass index, ER and PR, soyfood

Full Text

The Full Text of this article is available as a PDF (83.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlercreutz H., Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997 Apr;29(2):95–120. doi: 10.3109/07853899709113696. [DOI] [PubMed] [Google Scholar]
  2. Bruning P. F., Bonfrèr J. M., van Noord P. A., Hart A. A., de Jong-Bakker M., Nooijen W. J. Insulin resistance and breast-cancer risk. Int J Cancer. 1992 Oct 21;52(4):511–516. doi: 10.1002/ijc.2910520402. [DOI] [PubMed] [Google Scholar]
  3. Chen Z., Zheng W., Custer L. J., Dai Q., Shu X. O., Jin F., Franke A. A. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr Cancer. 1999;33(1):82–87. doi: 10.1080/01635589909514752. [DOI] [PubMed] [Google Scholar]
  4. Duncan A. M., Underhill K. E., Xu X., Lavalleur J., Phipps W. R., Kurzer M. S. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab. 1999 Oct;84(10):3479–3484. doi: 10.1210/jcem.84.10.6067. [DOI] [PubMed] [Google Scholar]
  5. Hankinson S. E., Willett W. C., Colditz G. A., Hunter D. J., Michaud D. S., Deroo B., Rosner B., Speizer F. E., Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998 May 9;351(9113):1393–1396. doi: 10.1016/S0140-6736(97)10384-1. [DOI] [PubMed] [Google Scholar]
  6. Hirose K., Tajima K., Hamajima N., Inoue M., Takezaki T., Kuroishi T., Yoshida M., Tokudome S. A large-scale, hospital-based case-control study of risk factors of breast cancer according to menopausal status. Jpn J Cancer Res. 1995 Feb;86(2):146–154. doi: 10.1111/j.1349-7006.1995.tb03032.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kelly G. E., Joannou G. E., Reeder A. Y., Nelson C., Waring M. A. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med. 1995 Jan;208(1):40–43. doi: 10.3181/00379727-208-43829. [DOI] [PubMed] [Google Scholar]
  8. Key T. J., Sharp G. B., Appleby P. N., Beral V., Goodman M. T., Soda M., Mabuchi K. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 1999 Dec;81(7):1248–1256. doi: 10.1038/sj.bjc.6690837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lee H. P., Gourley L., Duffy S. W., Estève J., Lee J., Day N. E. Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore. Cancer Causes Control. 1992 Jul;3(4):313–322. doi: 10.1007/BF00146884. [DOI] [PubMed] [Google Scholar]
  10. Lee H. P., Gourley L., Duffy S. W., Estéve J., Lee J., Day N. E. Dietary effects on breast-cancer risk in Singapore. Lancet. 1991 May 18;337(8751):1197–1200. doi: 10.1016/0140-6736(91)92867-2. [DOI] [PubMed] [Google Scholar]
  11. Lu L. J., Anderson K. E., Grady J. J., Kohen F., Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 2000 Aug 1;60(15):4112–4121. [PubMed] [Google Scholar]
  12. Messina M., Barnes S., Setchell K. D. Phyto-oestrogens and breast cancer. Lancet. 1997 Oct 4;350(9083):971–972. doi: 10.1016/S0140-6736(05)64062-7. [DOI] [PubMed] [Google Scholar]
  13. Pasquali R., Antenucci D., Melchionda N., Fabbri R., Venturoli S., Patrono D., Capelli M. Sex hormones in obese premenopausal women and their relationships to body fat mass and distribution, B cell function and diet composition. J Endocrinol Invest. 1987 Aug;10(4):345–350. doi: 10.1007/BF03348145. [DOI] [PubMed] [Google Scholar]
  14. Pino A. M., Valladares L. E., Palma M. A., Mancilla A. M., Yáez M., Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab. 2000 Aug;85(8):2797–2800. doi: 10.1210/jcem.85.8.6750. [DOI] [PubMed] [Google Scholar]
  15. Potischman N., Swanson C. A., Coates R. J., Gammon M. D., Brogan D. R., Curtin J., Brinton L. A. Intake of food groups and associated micronutrients in relation to risk of early-stage breast cancer. Int J Cancer. 1999 Jul 30;82(3):315–321. doi: 10.1002/(sici)1097-0215(19990730)82:3<315::aid-ijc1>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  16. Potischman N., Swanson C. A., Coates R. J., Weiss H. A., Brogan D. R., Stanford J. L., Schoenberg J. B., Gammon M. D., Brinton L. A. Dietary relationships with early onset (under age 45) breast cancer in a case-control study in the United States: influence of chemotherapy treatment. Cancer Causes Control. 1997 Sep;8(5):713–721. doi: 10.1023/a:1018475203820. [DOI] [PubMed] [Google Scholar]
  17. Potter J. D., Cerhan J. R., Sellers T. A., McGovern P. G., Drinkard C., Kushi L. R., Folsom A. R. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):319–326. [PubMed] [Google Scholar]
  18. Satia J. A., Patterson R. E., Herrero R., Jin F., Dai Q., King I. B., Chen C., Kristal A. R., Prentice R. L., Rossing M. A. Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica. Int J Cancer. 1999 Jul 2;82(1):28–32. doi: 10.1002/(sici)1097-0215(19990702)82:1<28::aid-ijc6>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  19. Siiteri P. K. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987 Jan;45(1 Suppl):277–282. doi: 10.1093/ajcn/45.1.277. [DOI] [PubMed] [Google Scholar]
  20. Thorsen T., Lahooti H., Rasmussen M., Aakvaag A. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):537–540. doi: 10.1016/0960-0760(92)90379-w. [DOI] [PubMed] [Google Scholar]
  21. Wagner J. D., Cefalu W. T., Anthony M. S., Litwak K. N., Zhang L., Clarkson T. B. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism. 1997 Jun;46(6):698–705. doi: 10.1016/s0026-0495(97)90016-0. [DOI] [PubMed] [Google Scholar]
  22. Wu A. H., Ziegler R. G., Horn-Ross P. L., Nomura A. M., West D. W., Kolonel L. N., Rosenthal J. F., Hoover R. N., Pike M. C. Tofu and risk of breast cancer in Asian-Americans. Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):901–906. [PubMed] [Google Scholar]
  23. Wu A. H., Ziegler R. G., Nomura A. M., West D. W., Kolonel L. N., Horn-Ross P. L., Hoover R. N., Pike M. C. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr. 1998 Dec;68(6 Suppl):1437S–1443S. doi: 10.1093/ajcn/68.6.1437S. [DOI] [PubMed] [Google Scholar]
  24. Zheng W., Dai Q., Custer L. J., Shu X. O., Wen W. Q., Jin F., Franke A. A. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):35–40. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES